Heterologous expression of the oxytetracycline biosynthetic pathway in Myxococcus xanthus
- PMID: 20208031
- PMCID: PMC2849223
- DOI: 10.1128/AEM.02841-09
Heterologous expression of the oxytetracycline biosynthetic pathway in Myxococcus xanthus
Abstract
New natural products for drug discovery may be accessed by heterologous expression of bacterial biosynthetic pathways in metagenomic DNA libraries. However, a "universal" host is needed for this experiment. Herein, we show that Myxococcus xanthus is a potential "universal" host for heterologous expression of polyketide biosynthetic gene clusters.
Figures


References
-
- Berdy, J. 2005. Bioactive microbial metabolites. J. Antibiot. (Tokyo) 58:1-26. - PubMed
-
- Gerth, K., S. Pradella, O. Perlova, S. Beyer, and R. Müller. 2003. Myxobacteria: proficient producers of novel natural products with various biological activities—past and future biotechnological aspects with the focus on the genus Sorangium. J. Biotechnol. 106:233-253. - PubMed
-
- Ginolhac, A., C. Jarrin, B. Gillet, P. Robe, P. Pujic, K. Tuphile, H. Bertrand, T. M. Vogel, G. Perriere, P. Simonet, and R. Nalin. 2004. Phylogenetic analysis of polyketide synthase I domains from soil metagenomic libraries allows selection of promising clones. Appl. Environ. Microbiol. 70:5522-5527. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources